Literature DB >> 8089212

Antibody for detecting p53 protein by immunohistochemistry in normal tissues.

F Pezzella1, K Micklem, H Turley, K Pulford, M Jones, S Kocialkowski, D Delia, A Aiello, R Bicknell, K Smith.   

Abstract

AIMS: To establish whether PAb248 recognises human p53 as well as murine p53 and if so, to determine its distribution in normal tissues.
METHODS: The ability of PAb248 to recognise human p53 was established by analysis of the human osteosarcoma derived Saos-2 cell line, which lacks the p53 gene, before and after transfection with p53 cDNA, using western blotting and immunoprecipitation. Immunostaining on normal tissues and cell lines was carried out using an immunoperoxidase technique. The two anti-p53 antibodies PAb 240 and DO-7 were used as controls.
RESULTS: The anti-p53 PAb248 monoclonal antibody stained the Saos-2 cell line after, but not before, transfection with p53 cDNA. Both western blots and immunoprecipitations performed with this antibody revealed a 53,000 molecular weight band. With immunostaining, this antibody detects p53 protein in most lymphoid and human epithelial cells in a cytoplasmic-perinuclear localisation that has not been described before. In the same tissues nuclear staining could be seen in a few scattered cells using the PAb240 antibody. The topographical distribution of wild type p53 was not related to proliferating areas but, rather, to short-lived populations of cells.
CONCLUSIONS: Immunostaining of wild type p53 is demonstrable not only in its nuclear form using antibody PAb240 but also in it common cytoplasmic-perinuclear localisation in normal tissues using the PAb248 monoclonal antibody. This opens up new possibilities for its study in both physiological and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8089212      PMCID: PMC502069          DOI: 10.1136/jcp.47.7.592

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  27 in total

1.  Rearrangement of the p53 gene in human osteogenic sarcomas.

Authors:  H Masuda; C Miller; H P Koeffler; H Battifora; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Monoclonal antibody analysis of p53 expression in normal and transformed cells.

Authors:  J W Yewdell; J V Gannon; D P Lane
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  Single and double immunoenzymatic techniques for labeling tissue sections with monoclonal antibodies.

Authors:  D Y Mason; Z Abdulaziz; B Falini; H Stein
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

4.  Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes.

Authors:  J Milner
Journal:  Nature       Date:  1984 Jul 12-18       Impact factor: 49.962

5.  p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells.

Authors:  W G Dippold; G Jay; A B DeLeo; G Khoury; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

6.  A new human B-cell non-Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t (14;18) and t(4;11) chromosomal translocations.

Authors:  M J Dyer; P Fischer; E Nacheva; W Labastide; A Karpas
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

7.  Expression of the nuclear oncogene p53 in colon tumours.

Authors:  F M van den Berg; A J Tigges; M E Schipper; F C den Hartog-Jager; W G Kroes; J M Walboomers
Journal:  J Pathol       Date:  1989-03       Impact factor: 7.996

8.  Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.

Authors:  D Wolf; V Rotter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

10.  P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibroblasts.

Authors:  V Rotter; H Abutbul; A Ben-Ze'ev
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  9 in total

1.  Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment.

Authors:  A Nickels; H Selter; M Pfreundschuh; M Montenarh; B Koch
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

2.  Endometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome.

Authors:  A M Gassel; J Backe; S Krebs; S Schön; H Caffier; H K Müller-Hermelink
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

3.  Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.

Authors:  C Lahoti; P Thorner; D Malkin; H Yeger
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

4.  p53 and angiogenesis in non-small-cell lung cancer.

Authors:  A Giatromanolaki; M I Koukourakis
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

5.  Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.

Authors:  C Milsmann; L Füzesi; E Heinmöller; P Krause; C Werner; H Becker; O Horstmann
Journal:  Langenbecks Arch Surg       Date:  2007-09-18       Impact factor: 3.445

6.  In situ detection of apoptosis at sites of chronic bacterially induced inflammation in human gingiva.

Authors:  M S Tonetti; D Cortellini; N P Lang
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

7.  p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.

Authors:  S Bosari; G Viale; M Roncalli; D Graziani; G Borsani; A K Lee; G Coggi
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

Review 8.  The clinical significance of p53 aberrations in human tumours.

Authors:  S Bosari; G Viale
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Expression and prognostic significance of Bcl-2 in ovarian tumours.

Authors:  R Henriksen; E Wilander; K Oberg
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.